Whitehawk Therapeutics Inc
WHWKLatest QuantConomy context for WHWK: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Whitehawk Therapeutics Inc
QuantConomy has a structured record for WHWK. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- WHWK
- Name
- Whitehawk Therapeutics Inc
- Coverage
- 2 market/data records
- Sources
- fmp alphavantage nasdaq
Recent signals for WHWK
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| eps change | very bearish | 80 | Jul 11, 12:00 AM | WHWK (Q1 2026, diluted eps): EPS turned negative ($1.83 → $-0.32). [year-over-year basis, very bearish signal] |
| net income change | very bearish | 85 | Jul 11, 12:00 AM | WHWK (Q1 2026, net income): swung to a loss ($73.02M → -$22.19M). [year-over-year basis, very bearish signal] |
| revenue change | very bearish | 76 | Jul 11, 12:00 AM | WHWK (Q1 2026, revenue): declined 100.0% ($7.14M → $0.00). [sequential period basis, very bearish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| WHWK | NASDAQ | fmp | Whitehawk Therapeutics Inc |
| WHWK | NASDAQ | alphavantage | Whitehawk Therapeutics Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Reeve Emma | Director | grant | 38,040 | — | — | 4 on EDGAR |
| Jun 12, 2026 | Aghazadeh Behzad | Director, 10% owner | grant | 38,040 | — | — | 4 on EDGAR |
| Jun 12, 2026 | Zhao Baiteng | Director | grant | 38,040 | — | — | 4 on EDGAR |
| Jun 12, 2026 | Desai Neil | Director | grant | 38,040 | — | — | 4 on EDGAR |
| Jun 12, 2026 | Hirmand Mohammad | Director | grant | 38,040 | — | — | 4 on EDGAR |
| Jun 12, 2026 | Maroun Richard E | Director | grant | 38,040 | — | — | 4 on EDGAR |
| Jun 12, 2026 | Castelein Caley | Director | grant | 38,040 | — | — | 4 on EDGAR |
| May 14, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | grant | 38,265 | $3.92 | $149,999 | 4 on EDGAR |
| May 14, 2026 | BALL BRYAN | See remarks | grant | 51,020 | $3.92 | $199,998 | 4 on EDGAR |
| May 14, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | grant | 51,021 | $3.92 | $200,002 | 4 on EDGAR |
| May 14, 2026 | Dugan Margaret | Chief Medical Officer | grant | 19,132 | $3.92 | $74,997 | 4 on EDGAR |
| May 14, 2026 | Castelein Caley | Director | grant | 255,102 | $3.92 | $1,000,000 | 4 on EDGAR |
| May 12, 2026 | Avoro Capital Advisors LLC | Insider | grant | 6,377,714 | $3.92 | $25,000,001 | 4 on EDGAR |
| Apr 15, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | sale | 77,000 | $3.86 | $297,220 | 4 on EDGAR |
| Apr 13, 2026 | BALL BRYAN | See remarks | sale | 26,389 | $3.46 | $91,306 | 4 on EDGAR |
| Apr 9, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | sale | 14,500 | $3.38 | $49,010 | 4 on EDGAR |
| Apr 9, 2026 | BALL BRYAN | See remarks | sale | 50,000 | $3.57 | $178,500 | 4 on EDGAR |
| Apr 6, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | sale | 102,395 | $3.51 | $359,406 | 4 on EDGAR |
| Apr 1, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | exercise | 473,902 | — | — | 4 on EDGAR |
| Apr 1, 2026 | BALL BRYAN | See remarks | exercise | 366,532 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query WHWK context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access